What question did this study set out to answer?

To determine whether activating the GLP-1 receptor with exendin-4 protects cortical and dopaminergic neurons from oxidative and metabolic insults in models of stroke and Parkinson's disease.

January 21, 2009Proceedings of the National Academy of SciencesOpen Access

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

View Full Paper

Ask AI

Bookmark

Authors

YLYazhou LiNational Institutes of Health TPTracyAnn PerryNational Institute on Aging MKMark S. KindyUniversity of South Florida

Discussion

Member takes

Implication

Preclinical study reveals that GLP-1 receptor activation preserves neurons in rodent models of stroke and Parkinson's disease, suggesting therapeutic potential for neurodegenerative conditions.

Key Points

To determine whether activating the GLP-1 receptor with exendin-4 protects cortical and dopaminergic neurons from oxidative and metabolic insults in models of stroke and Parkinson's disease.
Treated cultured embryonic primary cortical and dopaminergic neurons from wild-type and Glp1r knockout mice with GLP-1 or exendin-4 during exposure to hypoxia or 6-hydroxydopamine.
Evaluated infarct volume and neurological deficit after transient middle cerebral artery occlusion in rodents receiving exendin-4.
Assessed dopaminergic neuron survival, striatal dopamine concentrations, and motor behavior following exendin-4 administration in an MPTP-induced mouse model of Parkinson's disease.
GLP-1 and exendin-4 protected cultured cortical and dopaminergic neurons from hypoxia- and 6-hydroxydopamine-induced death in wild-type cells, but this protective effect was absent in Glp1r knockout cells.
Exendin-4 treatment significantly decreased cerebral damage and improved functional recovery following transient middle cerebral artery occlusion.
In MPTP-treated mice, exendin-4 attenuated dopaminergic neurodegeneration, maintained striatal dopamine levels, and substantially improved motor performance.

Cite This Study

Li et al. (2009) studied this question.

synapsesocial.com/papers/6a6fe206439bab0cabc2f017 https://doi.org/10.1073/pnas.0806720106

View Full Paper

Ask AI

Bookmark

Implication

Preclinical study reveals that GLP-1 receptor activation preserves neurons in rodent models of stroke and Parkinson's disease, suggesting therapeutic potential for neurodegenerative conditions.

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

Discussion

Member takes

Implication

Key Points

Cite This Study

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider